Published in J Clin Oncol on July 20, 2006
Oligometastases in prostate cancer: restaging stage IV cancers and new radiotherapy options. Radiat Oncol (2014) 1.52
The role of radiotherapy for metastatic epidural spinal cord compression. Nat Rev Clin Oncol (2010) 1.42
DEGRO practice guidelines for palliative radiotherapy of metastatic breast cancer: bone metastases and metastatic spinal cord compression (MSCC). Strahlenther Onkol (2009) 1.10
New prognostic factors and scoring system for patients with skeletal metastasis. Cancer Med (2014) 1.01
Treatment of painful bone metastases. Nat Rev Clin Oncol (2010) 0.98
A validated survival score for patients with metastatic spinal cord compression from non-small cell lung cancer. BMC Cancer (2012) 0.98
The NOMS framework: approach to the treatment of spinal metastatic tumors. Oncologist (2013) 0.97
Advance directives and do-not-resuscitate orders in patients with cancer with metastatic spinal cord compression: advanced care planning implications. J Palliat Med (2010) 0.90
Malignant spinal cord compression secondary to testicular seminoma at the time of initial presentation and at relapse while on surveillance. Can Urol Assoc J (2007) 0.90
A validated scoring system to identify long-term survivors after radiotherapy for metastatic spinal cord compression. Strahlenther Onkol (2013) 0.90
A new score predicting the survival of patients with spinal cord compression from myeloma. BMC Cancer (2012) 0.89
Radiotherapy for oligometastases and oligo-recurrence of bone in prostate cancer. Pulm Med (2012) 0.86
Prognostic factors for different outcomes in patients with metastatic spinal cord compression from cancer of unknown primary. BMC Cancer (2012) 0.86
Palliative radiation therapy in the management of brain metastases, spinal cord compression, and bone metastases. Semin Intervent Radiol (2007) 0.85
Percutaneous vertebroplasty in tumoral osteolysis. Eur Radiol (2007) 0.85
A new instrument for estimating the survival of patients with metastatic epidural spinal cord compression from esophageal cancer. Radiol Oncol (2015) 0.85
Prevalence of known and unknown primary tumor sites in spinal metastasis patients. Open Orthop J (2012) 0.84
Do elderly patients benefit from surgery in addition to radiotherapy for treatment of metastatic spinal cord compression? Strahlenther Onkol (2012) 0.83
A validated survival score for breast cancer patients with metastatic spinal cord compression. Strahlenther Onkol (2012) 0.81
Radiotherapy for oligometastatic disease in patients with spinal cord compression (MSCC) from relatively radioresistant tumors. Strahlenther Onkol (2010) 0.80
A new instrument for estimation of survival in elderly patients irradiated for metastatic spinal cord compression from breast cancer. Radiat Oncol (2015) 0.80
Reirradiation of spinal metastases with intensity-modulated radiation therapy: an analysis of 23 patients. J Radiat Res (2015) 0.80
Neurological outcome after emergency radiotherapy in MSCC of patients with non-small cell lung cancer--a prospective trial. Radiat Oncol (2013) 0.79
Radiotherapy or surgery for spine metastases? Acta Orthop (2011) 0.78
Dose-Fractionation Schedules for Radiotherapy of Bone Metastases. Breast Care (Basel) (2010) 0.76
Recovery from paraplegia with administration of erlotinib in a patient with lung adenocarcinoma. Contemp Oncol (Pozn) (2014) 0.75
Comparison of Short-Course Radiotherapy Versus Long-Course Radiotherapy for Treatment of Metastatic Spinal Cord Compression: A Systematic Review and Meta-Analysis. Medicine (Baltimore) (2015) 0.75
A predictive tool particularly designed for elderly myeloma patients presenting with spinal cord compression. BMC Cancer (2016) 0.75
Merkel Cell Spinal Metastasis: Management in the Setting of a Poor Prognosis. Global Spine J (2015) 0.75
A Simple Scoring System Predicting the Survival Time of Patients with Bone Metastases after RT. PLoS One (2016) 0.75
Effectiveness of radiotherapy for metastatic spinal cord compression in patients with short life expectancy. Rep Pract Oncol Radiother (2016) 0.75
CT-Guided (125)I Seed Interstitial Brachytherapy as a Salvage Treatment for Recurrent Spinal Metastases after External Beam Radiotherapy. Biomed Res Int (2016) 0.75
Preoperative prediction for regaining ambulatory ability in paretic non-ambulatory patients with metastatic spinal cord compression. Spinal Cord (2016) 0.75
A matched-pair analysis comparing 5x4 Gy and 10x3 Gy for metastatic spinal cord compression (MSCC) in patients with favorable survival prognoses. Radiat Oncol (2015) 0.75
Treatment for long bone metastases based on a systematic literature review. Eur J Orthop Surg Traumatol (2016) 0.75
Micro-invasive surgery combined with intraoperative radiotherapy for the treatment of spinal metastasis. Eur Spine J (2016) 0.75
Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship. Mayo Clin Proc (2008) 8.94
Newly discovered breast cancer susceptibility loci on 3p24 and 17q23.2. Nat Genet (2009) 7.30
Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the Breast Cancer Association Consortium studies. J Natl Cancer Inst (2010) 4.54
Magnetic resonance imaging for the detection, localisation, and characterisation of prostate cancer: recommendations from a European consensus meeting. Eur Urol (2010) 4.45
Prognostic value of tumor oxygenation in 397 head and neck tumors after primary radiation therapy. An international multi-center study. Radiother Oncol (2005) 3.86
Genome-wide association analysis identifies three new breast cancer susceptibility loci. Nat Genet (2012) 3.20
Low penetrance breast cancer susceptibility loci are associated with specific breast tumor subtypes: findings from the Breast Cancer Association Consortium. Hum Mol Genet (2011) 2.72
Phase III trial of prophylactic cranial irradiation compared with observation in patients with locally advanced non-small-cell lung cancer: neurocognitive and quality-of-life analysis. J Clin Oncol (2010) 2.71
Myocardial infarction mortality risk after treatment for Hodgkin disease: a collaborative British cohort study. J Natl Cancer Inst (2007) 2.65
Phase II trial of pemetrexed plus bevacizumab for second-line therapy of patients with advanced non-small-cell lung cancer: NCCTG and SWOG study N0426. J Clin Oncol (2009) 2.54
Changes in salivary gland function after radiotherapy of head and neck tumors measured by quantitative pertechnetate scintigraphy: comparison of intensity-modulated radiotherapy and conventional radiation therapy with and without Amifostine. Int J Radiat Oncol Biol Phys (2006) 2.48
Malignant melanoma in the 21st century, part 1: epidemiology, risk factors, screening, prevention, and diagnosis. Mayo Clin Proc (2007) 2.18
A new scoring system to predicting the survival of patients treated with whole-brain radiotherapy for brain metastases. Strahlenther Onkol (2008) 2.15
Hyperfractionated or accelerated radiotherapy in lung cancer: an individual patient data meta-analysis. J Clin Oncol (2012) 2.15
Single-dose brachytherapy versus metal stent placement for the palliation of dysphagia from oesophageal cancer: multicentre randomised trial. Lancet (2004) 2.06
Non-small cell lung cancer: histopathologic correlates for texture parameters at CT. Radiology (2012) 2.00
Surrogate endpoints for overall survival in chemotherapy and radiotherapy trials in operable and locally advanced lung cancer: a re-analysis of meta-analyses of individual patients' data. Lancet Oncol (2013) 1.99
Lung cancer perfusion at multi-detector row CT: reproducibility of whole tumor quantitative measurements. Radiology (2006) 1.91
Concerns about anti-angiogenic treatment in patients with glioblastoma multiforme. BMC Cancer (2009) 1.80
Evaluation of five radiation schedules and prognostic factors for metastatic spinal cord compression. J Clin Oncol (2005) 1.77
Breast cancer risk after supradiaphragmatic radiotherapy for Hodgkin's lymphoma in England and Wales: a National Cohort Study. J Clin Oncol (2012) 1.77
Effect of nitric-oxide synthesis on tumour blood volume and vascular activity: a phase I study. Lancet Oncol (2007) 1.76
Serious adverse effects of amifostine during radiotherapy in head and neck cancer patients. Radiother Oncol (2004) 1.74
Evaluation of 2 whole-brain radiotherapy schedules and prognostic factors for brain metastases in breast cancer patients. Cancer (2007) 1.73
Final results of a prospective study comparing the local control of short-course and long-course radiotherapy for metastatic spinal cord compression. Int J Radiat Oncol Biol Phys (2010) 1.68
Samarium-153-Lexidronam complex for treatment of painful bone metastases in hormone-refractory prostate cancer. Urology (2004) 1.67
The role of postoperative radiotherapy for the treatment of gangliogliomas. Cancer (2010) 1.67
Antivascular effects of neoadjuvant androgen deprivation for prostate cancer: an in vivo human study using susceptibility and relaxivity dynamic MRI. Int J Radiat Oncol Biol Phys (2010) 1.64
Surgical resection followed by whole brain radiotherapy versus whole brain radiotherapy alone for single brain metastasis. Int J Radiat Oncol Biol Phys (2008) 1.63
Phase III comparison of prophylactic cranial irradiation versus observation in patients with locally advanced non-small-cell lung cancer: primary analysis of radiation therapy oncology group study RTOG 0214. J Clin Oncol (2010) 1.63
Malignant melanoma in the 21st century, part 2: staging, prognosis, and treatment. Mayo Clin Proc (2007) 1.55
Analysis of gene expression using gene sets discriminates cancer patients with and without late radiation toxicity. PLoS Med (2006) 1.55
Individual radiosensitivity measured with lymphocytes may predict the risk of acute reaction after radiotherapy. Int J Radiat Oncol Biol Phys (2008) 1.50
Evaluation of salivary gland function after treatment of head-and-neck tumors with intensity-modulated radiotherapy by quantitative pertechnetate scintigraphy. Int J Radiat Oncol Biol Phys (2004) 1.50
Elective Nodal Irradiation (ENI) doesn't appear to provide a clear benefit for patients with unresectable non-small-cell lung cancer (NSCLC). Int J Radiat Oncol Biol Phys (2008) 1.49
In regard to the radiotherapy of myxopapillary ependymomas. Int J Radiat Oncol Biol Phys (2002) 1.48
Loss of expression of the tumour suppressor gene AIMP3 predicts survival following radiotherapy in muscle-invasive bladder cancer. Int J Cancer (2014) 1.45
Prophylactic vesical instillations with 0.2% chondroitin sulfate may reduce symptoms of acute radiation cystitis in patients undergoing radiotherapy for gynecological malignancies. Int Urogynecol J (2011) 1.45
Analysis of biochemical control and prognostic factors in patients treated with either low-dose three-dimensional conformal radiation therapy or high-dose intensity-modulated radiotherapy for localized prostate cancer. Int J Radiat Oncol Biol Phys (2007) 1.45
Acute toxicity of three versus two courses of cisplatin for radiochemotherapy of locally advanced squamous cell carcinoma of the head and neck (SCCHN): a matched pair analysis. Oral Oncol (2010) 1.40
Impaired survival and long-term neurological problems in benign meningioma. Neuro Oncol (2012) 1.37
HNSCC cell lines positive for HPV and p16 possess higher cellular radiosensitivity due to an impaired DSB repair capacity. Radiother Oncol (2013) 1.32
Second cancer risk after chemotherapy for Hodgkin's lymphoma: a collaborative British cohort study. J Clin Oncol (2011) 1.30
The first score predicting overall survival in patients with metastatic spinal cord compression. Cancer (2008) 1.28
Should elderly non-small-cell lung cancer patients be offered elderly-specific trials? Results of a pooled analysis from the North Central Cancer Treatment Group. J Clin Oncol (2005) 1.27
Treatment of non-small cell lung cancer, stage IIIB: ACCP evidence-based clinical practice guidelines (2nd edition). Chest (2007) 1.27
11q13 is a susceptibility locus for hormone receptor positive breast cancer. Hum Mutat (2012) 1.26
A prognostic model for advanced stage nonsmall cell lung cancer. Pooled analysis of North Central Cancer Treatment Group trials. Cancer (2006) 1.26
Randomized trial of 8 Gy in 1 versus 20 Gy in 5 fractions of radiotherapy for neuropathic pain due to bone metastases (Trans-Tasman Radiation Oncology Group, TROG 96.05). Radiother Oncol (2004) 1.25
Risk of second malignancy after non-Hodgkin's lymphoma: a British Cohort Study. J Clin Oncol (2006) 1.24
Primary non-Hodgkin lymphoma of the breast: The Mayo Clinic Experience. J Surg Oncol (2002) 1.23
Confirmation of 5p12 as a susceptibility locus for progesterone-receptor-positive, lower grade breast cancer. Cancer Epidemiol Biomarkers Prev (2011) 1.23
Adjuvant external beam radiation therapy with concurrent chemotherapy in the management of gallbladder carcinoma. Int J Radiat Oncol Biol Phys (2002) 1.21
Atypical and malignant meningioma: outcome and prognostic factors in 119 irradiated patients. A multicenter, retrospective study of the Rare Cancer Network. Int J Radiat Oncol Biol Phys (2008) 1.19
Quantitative assessment of lung cancer perfusion using MDCT: does measurement reproducibility improve with greater tumor volume coverage? AJR Am J Roentgenol (2006) 1.19
Increasing the rate of late toxicity by changing the score? A comparison of RTOG/EORTC and LENT/SOMA scores. Int J Radiat Oncol Biol Phys (2003) 1.18
Evaluation of ki-67 staining levels as an independent biomarker of biochemical recurrence after salvage radiation therapy for prostate cancer. Int J Radiat Oncol Biol Phys (2009) 1.18
Stereotactic radiosurgery alone versus resection plus whole-brain radiotherapy for 1 or 2 brain metastases in recursive partitioning analysis class 1 and 2 patients. Cancer (2007) 1.17
Valproic acid sensitizes human glioma cells for temozolomide and γ-radiation. J Neurooncol (2011) 1.17
Endpoints in phase II trials for advanced non-small cell lung cancer. J Thorac Oncol (2010) 1.16
Differential radiosensitizing potential of temozolomide in MGMT promoter methylated glioblastoma multiforme cell lines. Int J Radiat Oncol Biol Phys (2007) 1.16
Prognostic model for survival in patients with early stage cervical cancer. Cancer (2010) 1.16
Cognitive rehabilitation in patients with gliomas: a randomized, controlled trial. J Clin Oncol (2009) 1.16
Central neurocytoma: management recommendations based on a 35-year experience. Int J Radiat Oncol Biol Phys (2006) 1.16
Prognostic factors differ by tumor stage for small cell lung cancer: a pooled analysis of North Central Cancer Treatment Group trials. Cancer (2009) 1.15
Nijmegen Breakage Syndrome mutations and risk of breast cancer. Int J Cancer (2008) 1.14
Individual radiosensitivity measured with lymphocytes may be used to predict the risk of fibrosis after radiotherapy for breast cancer. Radiother Oncol (2003) 1.14
Technical innovations of carinal resection for nonsmall-cell lung cancer. Ann Thorac Surg (2006) 1.14
Dose escalation of radiotherapy for metastatic spinal cord compression (MSCC) in patients with relatively favorable survival prognosis. Strahlenther Onkol (2011) 1.14
Comparison of 6q25 breast cancer hits from Asian and European Genome Wide Association Studies in the Breast Cancer Association Consortium (BCAC). PLoS One (2012) 1.13
Efficacy of intensified hyperfractionated and accelerated radiotherapy and concurrent chemotherapy with carboplatin and 5-fluorouracil: updated results of a randomized multicentric trial in advanced head-and-neck cancer. Int J Radiat Oncol Biol Phys (2006) 1.13